These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 311801)

  • 21. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo.
    Priest DG; Bunni M; Sirotnak FM
    Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
    Assaraf YG; Ifergan I; Kadry WN; Pinter RY
    J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
    Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of leucovorin rescue using a new methotrexate-independent biochemical assay for leucovorin and N5-methyltetrahydrofolate.
    Hamel E; Johnson G; Glaubiger D
    Cancer Treat Rep; 1981; 65(7-8):545-53. PubMed ID: 7018678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspects of the reversal of methotrexate toxicity in rodents.
    Kisliuk RL; Tattersall MH; Gaumont Y; Pastore EJ; Brown B
    Cancer Treat Rep; 1977 Jul; 61(4):647-50. PubMed ID: 301779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
    Boarman DM; Baram J; Allegra CJ
    Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-presssure liquid chromatographic determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, in human plasma.
    Watson E; Cohen JL; Chan KK
    Cancer Treat Rep; 1978 Mar; 62(3):381-7. PubMed ID: 647697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate analogues as substrates of mammalian folylpolyglutamate synthetase.
    Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG
    Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
    Henderson GB; Strauss BP
    Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
    Refsum H; Wesenberg F; Ueland PM
    Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of methotrexate on thymidylate synthetase in cultured parenchymal cells isolated from regenerating rat liver.
    Bonney RJ; Maley F
    Cancer Res; 1975 Aug; 35(8):1950-6. PubMed ID: 1170938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
    Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring the administration of methotrexate in antimetabolite therapy.
    Epstein E; Baginski ES; Zac B
    Ann Clin Lab Sci; 1976; 6(4):312-7. PubMed ID: 9024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy.
    Mei S; Shi X; Du Y; Cui Y; Zeng C; Ren X; Yu K; Zhao Z; Lin S
    J Pharm Biomed Anal; 2018 Sep; 158():300-306. PubMed ID: 29909319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid.
    Belz S; Frickel C; Wolfrom C; Nau H; Henze G
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):109-18. PubMed ID: 7866539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.